Related Experiment Video
Updated: Jun 13, 2025

10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.5K
Progressive vulnerability of cortical synapses in α-synucleinopathy.
Biorxiv : the Preprint Server for Biology
|June 12, 2025
Summary
Alpha-synuclein pathology progressively damages intracortical excitatory synapses in the brain, impacting cognitive function in neurodegenerative diseases like Parkinson's. Resilience mechanisms and spared long-range synapses offer potential therapeutic targets.
Area of Science:
- Neuroscience
- Synaptic Plasticity
- Neurodegenerative Diseases
Background:
- Alpha-synuclein (α-syn) aggregates are key pathological hallmarks in neurodegenerative disorders such as Parkinson's disease and dementia with Lewy bodies.
- Cortical α-syn pathology is linked to cognitive decline, suggesting a disruption of neural connectivity.
Purpose of the Study:
- To investigate the progressive impact of α-syn pathology on synaptic connectivity within the frontal cortex.
- To identify specific synapse types vulnerable or resilient to α-syn accumulation and characterize underlying mechanisms.
Main Methods:
- High-resolution imaging (including electron microscopy) to assess synaptic structure and density.
- Gene expression analysis (ontology) in affected neurons to identify molecular pathways.
- Neuroanatomical connectivity mapping and electrophysiological recordings.
Main Results:
- Progressive loss and structural disruption of intracortical excitatory (VGLUT1+) synapses near α-syn aggregates.
- Synaptic α-syn accumulation correlated with synapse loss; altered gene expression suggested resilience mechanisms.
- Intratelencephalic (IT) projection neurons in layer V were vulnerable, while long-range excitatory (VGLUT2+) synapses were spared.
- Inhibitory (VGAT+) synapses showed late-stage modest impact; impaired excitatory transmission was confirmed electrophysiologically.
Conclusions:
- Intracortical synapses are a primary locus of connectivity disruption in α-synucleinopathies.
- Synapse-type specific vulnerabilities and resilience mechanisms are evident in the progression of these diseases.
- Understanding these synaptic changes is crucial for developing targeted therapies for cognitive decline in α-synucleinopathies.
Related Concept Videos
Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K

